| eerste vaccinatie tegen 'severe acute respiratory syndrome'-coronavirus 2 met 'messenger'-ribonucleïnezuurvaccin (verrichting) | 
|  | eerste vaccinatie tegen SARS-CoV-2 met mRNA-vaccin | 
|  | eerste vaccinatie tegen 'severe acute respiratory syndrome'-coronavirus 2 met 'messenger'-ribonucleïnezuurvaccineerste toediening van mRNA-vaccin tegen COVID-19
 eerste actieve immunisatie met SARS-CoV-2-mRNA-vaccin
 
 | 
|  | Administration of first dose of SARS-CoV-2 mRNA vaccine | 
|  | Administration of first dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acidFirst 2019 novel coronavirus mRNA immunization
 First 2019-nCoV mRNA vaccination
 First severe acute respiratory syndrome coronavirus 2 mRNA vaccination
 First SARS-CoV-2 mRNA vaccination
 First 2019-nCoV mRNA immunization
 First 2019 novel coronavirus mRNA vaccination
 First COVID-19 mRNA immunization
 First SARS-CoV-2 mRNA immunization
 First COVID-19 mRNA vaccination
 
 |